Srijaipracharoen Sunamchok, Tangjitgamol Siriwan, Tanvanich Sujitra, Manusirivithaya Sumonmal, Khunnarong Jakkapan, Thavaramara Thaovalai, Leelahakorn Surawute, Pataradool Kamol
Department of Obstetrics and Gynecology, Bangkok Metropolitan Administration Medical College and Vajira Hospital, Bangkok, Thailand.
Asian Pac J Cancer Prev. 2010;11(1):215-20.
To determine any association between expression of estrogen receptor (ER), progesterone receptor (PR), and Her-2/neu and clinicopathological features, including survival, of endometrial carcinoma (EMC) patients.
Samples of formalin-fixed, paraffin-embedded tissue of 108 patients with EMC treated at our institution between January 1994 and December 2007 were immunohistochemically studied.
ER, PR, and Her-2/neu expression were positive in 59.3%, 65.7% and 2.8% of cases, respectively. Positive ER expression was significantly associated with grade I-II tumor while PR expression was linked with endometrioid histology, grade I-II tumor, less myometrial invasion (MI) and negative lymph node involvement. Her-2/neu expression was significantly associated with deep MI, while positive ER and negative Her-2/neu expression in combination was significantly associated with longer disease-free and overall survival.
ER expression is a good prognostic factor while Her-2/neu expression appears to be a poor indicator for both disease-free and overall survival, while PR tended to show favorable influence for only disease-free survival of Thai EMCs.
确定子宫内膜癌(EMC)患者雌激素受体(ER)、孕激素受体(PR)和Her-2/neu的表达与包括生存率在内的临床病理特征之间的任何关联。
对1994年1月至2007年12月在本机构接受治疗的108例EMC患者的福尔马林固定、石蜡包埋组织样本进行免疫组织化学研究。
ER、PR和Her-2/neu表达分别在59.3%、65.7%和2.8%的病例中呈阳性。ER阳性表达与I-II级肿瘤显著相关,而PR表达与子宫内膜样组织学、I-II级肿瘤、较少的肌层浸润(MI)和阴性淋巴结受累有关。Her-2/neu表达与深部MI显著相关,而ER阳性和Her-2/neu阴性表达相结合与更长的无病生存期和总生存期显著相关。
ER表达是一个良好的预后因素,而Her-2/neu表达似乎是无病生存期和总生存期的不良指标,而PR仅对泰国EMC的无病生存期有有利影响。